ClinConnect ClinConnect Logo
Search / Trial NCT05679284

A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs

Launched by TAMPERE UNIVERSITY HOSPITAL · Jan 9, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Intravenous Drug Use Needle Retention Needle Fragment

ClinConnect Summary

This clinical trial is studying the issue of retained needle fragments in people who use intravenous drugs (IVD). When someone injects drugs, small pieces of the needle can sometimes break off and stay in the body, which can lead to pain, infections, and even serious complications like damage to organs. The researchers want to find out how common this problem is and what factors might increase the risk of having these needle fragments.

To participate in the study, you need to have a history of using intravenous drugs and be currently receiving treatment for drug abuse at a local health service. If you join, you will fill out a questionnaire and have X-ray imaging done to check for any retained needle fragments. This study is looking for participants of any gender who are between the ages of 18 and 74. It’s important to know that if you are pregnant or do not meet the inclusion criteria, you won't be able to participate. By taking part in this research, you will help provide valuable information that could benefit others in similar situations.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • History of intravenous drug use
  • Current treatment of the drug abuse problem at a local low-threshold drug abuse service unit or primary health care centre.
  • Adherence to fill in the questionnaire
  • Participation to X-ray imaging of injection sites
  • Exclusion Criteria:
  • No history of intravenous drug use
  • Does not adhere to fill in the questionnaire or refuses X-ray imaging
  • Pregnancy
  • Underage (18 years old)

About Tampere University Hospital

Tampere University Hospital (TAYS) is a leading academic medical center in Finland, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, TAYS integrates cutting-edge medical practices with rigorous scientific investigation, focusing on improving patient outcomes and enhancing treatment modalities across various specialties. The hospital collaborates with a network of researchers, healthcare professionals, and academic institutions to foster a multidisciplinary approach to medical research, ensuring that findings are translated into real-world applications for the benefit of patients and the broader healthcare community.

Locations

Tampere, , Finland

Patients applied

PB

1 patients applied

Trial Officials

Otso Arponen, MD-PhD

Study Chair

Pirkanmaa Hospital District (PSHP)

Olli PO Nevalainen, MD-PhD

Study Chair

City of Tampere; Tampere University; Pirkanmaa Hospital District (PSHP).

Irina Rinta-Kiikka, MD-PhD

Study Chair

Tampere University Hospital

Heidi Laukkala, MD

Study Chair

City of Tampere, Tampere University

Markku Sumanen, MD-PhD

Principal Investigator

Tampere University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials